Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2015 - 2026)
Tonix Pharmaceuticals Holding (TNXP) recorded Interest & Investment Income of $1.35 million in Q1 2026, up 241.6% from $394,000 a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2015 - 2026) Analysis & Trends
On a TTM basis, Tonix Pharmaceuticals Holding's Interest & Investment Income came in at $4.32 million as of Mar 31, 2026, up 927.4% year-over-year; for FY2025, it was $4.15 million.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 143.9% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $22,000 in FY2024 (-98.7%), $1.72 million in FY2023 (-8.1%), $1.87 million in FY2022 and $25,000 in FY2021 (-47.9%).
- The Q1 2026 figure is the highest quarterly Interest & Investment Income in data going back to Q1 2015.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 241.6% in Q1 2026, against a decline of 99.3% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 149.62 Mn | 149.62 Mn | 12.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 646,000.00 |
| Mar 31, 2023 | 897,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 610,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | -74,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 83,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 9,000.00 |
API Access
Tonix Pharmaceuticals Holding Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();